ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesR87.69

R87.69

Abnormal cytological findings in specimens from other female genital organs

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/11/2025

Code Description

ICD-10 R87.69 is a billable code used to indicate a diagnosis of abnormal cytological findings in specimens from other female genital organs.

Key Diagnostic Point:

R87.69 is used to classify abnormal cytological findings in specimens obtained from female genital organs other than the cervix and uterus. This code encompasses a range of abnormal findings that may arise from various conditions affecting the ovaries, fallopian tubes, vulva, and vagina. Common cytological abnormalities may include atypical squamous cells, glandular cells, or other cellular changes indicative of infection, inflammation, or neoplastic processes. These findings are often identified through Pap smears, biopsies, or other cytological examinations. The clinical significance of these findings can vary widely, necessitating further diagnostic evaluation to determine the underlying cause, which may include infections (e.g., HPV, candidiasis), benign lesions (e.g., cysts, fibromas), or malignancies. Accurate coding of R87.69 requires thorough documentation of the cytological findings and any associated clinical symptoms, as well as the context in which the specimens were collected.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of potential underlying conditions
  • Need for precise documentation of cytological findings
  • Differentiation from other related codes
  • Potential for overlapping symptoms with other diagnoses

Audit Risk Factors

  • Inadequate documentation of cytological findings
  • Misclassification of abnormal findings
  • Failure to specify the site of the specimen collection
  • Lack of follow-up documentation for abnormal results

Specialty Focus

Medical Specialties

Internal Medicine

Documentation Requirements

Detailed documentation of cytological findings, patient history, and any relevant symptoms.

Common Clinical Scenarios

Routine screening for cervical cancer, follow-up on abnormal Pap results, evaluation of pelvic pain.

Billing Considerations

Ensure that all findings are clearly linked to the diagnosis and that any follow-up actions are documented.

Emergency Medicine

Documentation Requirements

Acute care documentation including reason for specimen collection and any immediate findings.

Common Clinical Scenarios

Acute presentations of pelvic pain, abnormal bleeding, or suspected infections.

Billing Considerations

Document the urgency of the situation and any immediate interventions performed.

Coding Guidelines

Inclusion Criteria

Use R87.69 When
  • Follow the official ICD
  • CM coding guidelines, ensuring that the code is used only when there are documented abnormal cytological findings from female genital organs other than the cervix and uterus
  • Ensure that the findings are not classified under other specific codes

Exclusion Criteria

Do NOT use R87.69 When
No specific exclusions found.

Related CPT Codes

88141CPT Code

Cytopathology, cervical or vaginal, screening

Clinical Scenario

Used when performing a Pap smear with abnormal findings.

Documentation Requirements

Document the reason for the Pap smear and any abnormal findings.

Specialty Considerations

Ensure that the procedure is linked to the diagnosis of abnormal cytological findings.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of abnormal cytological findings, improving the accuracy of data collection and reimbursement processes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of abnormal cytological findings, improving the accuracy of data collection and reimbursement processes.

Reimbursement & Billing Impact

reimbursement processes.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What types of findings are classified under R87.69?

R87.69 includes abnormal cytological findings from female genital organs other than the cervix and uterus, such as atypical cells from the ovaries, fallopian tubes, vulva, or vagina.

How should I document findings for R87.69?

Document the specific cytological findings, the site of specimen collection, and any relevant clinical symptoms or history to support the diagnosis.